Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis

NCT02606032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Metronidazole
DRUG: Doxycycline
DRUG: Terbinafine
DRUG: Placebo

Sponsor

Hamilton Health Sciences Corporation

Collaborators

[object Object]